Stanley Druckenmiller portfolio: holdings and latest trades
The stocks Duquesne Family Office reported in its latest 13F filing, for Q2 2026: 86 positions worth about $4.4B, what was bought and sold in the quarter, and who Druckenmiller is.
Data updated August 14, 2026 (13F for Q2 2026)
- 13F portfolio value
- $4.4B
- Positions
- 86
- Top 10 holdings
- 52%
- Change in value vs previous quarter
- +51.7%
Stanley Druckenmiller top holdings (Q2 2026)
| # | Stock | % of portfolio | Value | Last quarter |
|---|---|---|---|---|
| 1 | NTRA Natera Inc | 19.9% | $865M | Added 4% |
| 2 | TSM Taiwan Semiconductor-Sp ADR | 6.5% | $282M | Added 19% |
| 3 | STM Stmicroelectronics Nv-Ny Shs | 5.3% | $232M | Added 19% |
| 4 | INSM Insmed Inc | 3.5% | $152M | Added 23% |
| 5 | YPF Ypf S.A.-Sponsored ADR | 3.3% | $143M | Trimmed 3% |
| 6 | AMZN Amazon.Com Inc | 3.0% | $129M | Added 1083% |
| 7 | TBBB Bbb Foods Inc | 2.8% | $121M | Trimmed 7% |
| 8 | GOOGL Alphabet Inc-Cl A | 2.8% | $120M | New |
| 9 | EWZ iShares Msci Brazil ETF | 2.7% | $119M | Unchanged |
| 10 | FOXA Fox Corp - Class A | 2.6% | $115M | New |
| 11 | UAL United Airlines Holdings Inc | 2.5% | $108M | Added 203% |
| 12 | SE Sea Ltd-ADR | 2.4% | $105M | Unchanged |
| 13 | CDW Cdw Corp/De | 2.4% | $105M | New |
| 14 | NAMS Newamsterdam Pharma Company | 2.4% | $104M | Unchanged |
| 15 | SNDK Sandisk Corp | 1.8% | $79M | Trimmed 8% |
| 16 | RVMD Revolution Medicines Inc | 1.7% | $75M | Added 27% |
| 17 | BTDR Bitdeer Technologies Group | 1.5% | $65M | New |
| 18 | DAL Delta Air Lines Inc | 1.3% | $56M | New |
| 19 | FLR Fluor Corp | 1.2% | $51M | New |
| 20 | DHI Dr Horton Inc | 1.1% | $49M | New |
| 21 | CPNG Coupang Inc | 1.1% | $46M | Unchanged |
| 22 | AMD Advanced Micro Devices | 1.0% | $42M | New |
| 23 | PANW Palo Alto Networks Inc | 0.9% | $40M | New |
| 24 | CLF Cleveland-Cliffs Inc | 0.9% | $40M | Added 82% |
| 25 | HUT Hut 8 Corp | 0.8% | $36M | New |
| 26 | CAI Caris Life Sciences Inc | 0.8% | $34M | Unchanged |
| 27 | ARGT Global X Msci Argentina ETF | 0.7% | $30M | Trimmed 15% |
| 28 | FOX Fox Corp - Class B | 0.7% | $30M | New |
| 29 | WWD Woodward Inc | 0.7% | $29M | Trimmed 68% |
| 30 | NUVB Nuvation Bio Inc | 0.6% | $26M | Unchanged |
Showing the 30 largest of 86 positions.
What Druckenmiller bought and sold in Q2 2026
Bought or added
- GOOGL Alphabet Inc-Cl ANew
- AMZN Amazon.Com IncAdded 1083%
- FOXA Fox Corp - Class ANew
- CDW Cdw Corp/DeNew
- UAL United Airlines Holdings IncAdded 203%
- — Seagate Technology Hldngs PlAdded 141%
- BTDR Bitdeer Technologies GroupNew
- DAL Delta Air Lines IncNew
- FLR Fluor CorpNew
- DHI Dr Horton IncNew
Sold or reduced
- ROKU Roku IncTrimmed 75%
- AA Alcoa CorpTrimmed 88%
- WWD Woodward IncTrimmed 68%
- AVGO Broadcom IncSold out
- — Teva Pharmaceutical Inds LtdTrimmed 74%
- OPCH Option Care Health IncSold out
- FIGR Figure Technology Solut-Cl ASold out
- QSR Restaurant Brands InternSold out
- LSCC Lattice Semiconductor CorpSold out
- ARM Arm Holdings Plc-ADRTrimmed 74%
Changes in number of shares against the 13F for the previous quarter (Q1 2026), largest first.
Who is Stanley Druckenmiller
- Role
- Founder of Duquesne Capital, now a family office
- Fund
- Duquesne Family Office, founded 1981
- Investment style
- Macro-driven, concentrated and willing to change positions quickly.
- Known for
- The 1992 pound trade at the Quantum Fund
Stanley Druckenmiller founded Duquesne Capital in 1981 and from 1988 also managed George Soros’s Quantum Fund, where he led the 1992 bet against the pound. Duquesne posted no losing year over three decades before he returned outside money in 2010.
He now manages his own wealth through the Duquesne Family Office, whose 13F is followed for his large, fast-moving bets on technology and other sectors.
- •The 1992 pound trade at the Quantum Fund
- •Three decades without a losing year at Duquesne
- •Concentrated, quickly changing positions
How to read 13F data
A 13F filing lists the US-listed stocks, ETFs and some options a manager held at the end of a quarter. It is filed up to 45 days after the quarter ends, so positions may have changed since. It does not show short positions, bonds, cash, foreign-listed shares or private investments, so for many funds it is only part of the picture.
Questions
What stocks does Stanley Druckenmiller own?
According to the 13F filing of Duquesne Family Office for Q2 2026 (period ending June 30, 2026), the largest holdings were Natera Inc (NTRA) 19.9%, Taiwan Semiconductor-Sp ADR (TSM) 6.5%, Stmicroelectronics Nv-Ny Shs (STM) 5.3%, Insmed Inc (INSM) 3.5%, Ypf S.A.-Sponsored ADR (YPF) 3.3%, out of 86 positions worth about $4.4B.
What did Druckenmiller buy and sell last quarter?
New or larger positions in Q2 2026: GOOGL, AMZN, FOXA, CDW, UAL, Seagate Technology Hldngs Pl. Sold or reduced: ROKU, AA, WWD, AVGO, Teva Pharmaceutical Inds Ltd, OPCH. Changes are measured in shares against the previous quarter’s filing.
How up to date is Duquesne Family Office’s portfolio?
13F filings are due within 45 days after each quarter ends. This page shows the filing made on August 14, 2026 for the quarter ended June 30, 2026; the fund may have traded since.
What does a 13F filing leave out?
A 13F filing lists the US-listed stocks, ETFs and some options a manager held at the end of a quarter. It is filed up to 45 days after the quarter ends, so positions may have changed since. It does not show short positions, bonds, cash, foreign-listed shares or private investments, so for many funds it is only part of the picture.
Other famous investors
- All famous investorsHoldings and latest trades
- Warren BuffettBerkshire Hathaway
- Michael BurryScion Asset Management
- Bill AckmanPershing Square Capital
- Ray DalioBridgewater Associates
- Cathie WoodARK Investment Management
- Bill GatesGates Foundation Trust
- George SorosSoros Fund Management
- Carl IcahnIcahn Enterprises
- Seth KlarmanBaupost Group
- Li LuHimalaya Capital
- David TepperAppaloosa
Source: SEC Form 13F-HR filings via EDGAR. Holdings are as reported by the manager for the quarter shown and may have changed since. Educational content, not investment advice: MEDGE Capital does not recommend buying or selling any security. Risk disclaimer.